Concepedia

Ingrid L. Scully

IL

Statistics

Publications

38

Citations

4.8K

H-Index

24

Active since

2012

Affiliations

Pfizer (United States)(Current)

BioNTech (Germany)

University Medical Center of the Johannes Gutenberg University Mainz

Johannes Gutenberg University Mainz

The University of Texas Medical Branch at Galveston

Ingrid L. Scully is an author at Pfizer (United States) specializing in vaccinology, immunology, and infectious diseases.

ORCID

Publications per year

2012–2025

38

Publications

38

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

, , +16

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel, Isis Kanevsky, Ye Che et al. · Nature · 2021 · 741 citations · Full text

, , +14

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

Brandon Essink, Charu Sabharwal, Kevin Cannon et al. · Clinical Infectious Diseases · 2021 · 172 citations · Full text

, , +17

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

Donald Hurley, Carl Griffin, Mariano Young et al. · Clinical Infectious Diseases · 2020 · 157 citations · Full text

, , +17

A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

Annette B. Vogel, Isis Kanevsky, Ye Che et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 139 citations · Full text

, , +17

1–5 of 38